Cancer Letters
Volume 253, Issue 1 , Pages 124-130 , 8 August 2007

Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase

  • Francesca Scarlatti

      Affiliations

    • Laboratory of Biochemistry & Mol Biology, San Paolo Medical School, University of Milan, Italy
    • ,
  • Giusy Sala

      Affiliations

    • Laboratory of Biochemistry & Mol Biology, San Paolo Medical School, University of Milan, Italy
    • ,
  • Clara Ricci

      Affiliations

    • Laboratory of Biochemistry & Mol Biology, San Paolo Medical School, University of Milan, Italy
    • ,
  • Claudio Maioli

      Affiliations

    • Institute of Radiological Sciences, University of Milan, Italy
    • ,
  • Franco Milani

      Affiliations

    • Institute of Radiological Sciences, University of Milan, Italy
    • ,
  • Marco Minella

      Affiliations

    • Servizio di Fisica Sanitaria, Niguarda Hospital, Milan, Italy
    • ,
  • Marco Botturi

      Affiliations

    • Radiotherapy Service, Niguarda Hospital, Milan, Italy
    • ,
  • Riccardo Ghidoni

      Affiliations

    • Laboratory of Biochemistry & Mol Biology, San Paolo Medical School, University of Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0250323250; fax: +39 0250323245.

Received 29 November 2006 ,Revised 18 January 2007 ,Accepted 19 January 2007.

References 

  1. Hagan M, Wang L, Hanley JR, Park JS, Dent P. Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest. Radiat. Res. 2000;153:371–383
  2. Crook JM, Perry GA, Robertson S, Esche BA. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology. 1995;45:624–631discussion 631–622
  3. Forman JD, Oppenheim T, Liu H, Montie J, McLaughlin PW, Porter AT. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy. Prostate. 1993;23:235–243
  4. Bowen C, Spiegel S, Gelmann EP. Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res. 1998;58:3275–3281
  5. Yacoub A, Park JS, Qiao L, Dent P, Hagan MP. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. Int. J. Radiat. Biol. 2001;77:1067–1078
  6. Sasaki R, Shirakawa T, Zhang ZJ, Tamekane A, Matsumoto A, Sugimura K, et al. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 2001;51:1336–1345
  7. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218–220
  8. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 2000;130:467S–471S
  9. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001;22:1111–1117
  10. Morris GZ, Williams RL, Elliott MS, Beebe SJ. Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate. 2002;52:319–329
  11. Hsieh TC, Wu JM. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 1999;249:109–115
  12. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA, et al. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J. Urol. 2002;168:748–755
  13. Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat. Res. 2001;496:171–180
  14. Kim YA, Rhee SH, Park KY, Choi YH. Antiproliferative effect of resveratrol in human prostate carcinoma cells. J. Med. Food. 2003;6:273–280
  15. Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER, Reddy GP. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res. 2002;62:2488–2492
  16. Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?. Cancer Invest. 1992;10:229–240
  17. Allan DJ. Radiation-induced apoptosis: its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int. J. Radiat Biol. 1992;62:145–152
  18. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855–1859
  19. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 1994;54:2591–2597
  20. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 1996;86:189–199
  21. Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 1997;57:1270–1275
  22. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994;54:2582–2590
  23. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 1991;138:447–453
  24. Hara S, Nakashima S, Kiyono T, Sawada M, Yoshimura S, Iwama T, et al. Ceramide triggers caspase activation during gamma-radiation-induced apoptosis of human glioma cells lacking functional p53. Oncol. Rep. 2004;12:119–123
  25. Kimura K, Markowski M, Edsall LC, Spiegel S, Gelmann EP. Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells. Cell Death Differ. 2003;10:240–248
  26. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, et al. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate. 2004;58:382–393
  27. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 2003;17:2339–2341
  28. Sala G, Minutolo F, Macchia M, Sacchi N, Ghidoni R. Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs Exp. Clin. Res. 2003;29:263–269
  29. Chaudhry M, Sundaram S, Gennings C, Carter H, Gewirtz DA. The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells. Cancer Chemother. Pharmacol. 2001;47:429–436
  30. Chou TC, Talalay P. Quantitative analysis of dose–effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984;22:27–55
  31. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959;37:911–917
  32. Perry DK, Hannun YA. The use of diglyceride kinase for quantifying ceramide. Trends Biochem. Sci. 1999;24:226–227
  33. Ames BN, Dubin DT. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 1960;235:769–775
  34. Chou TC, Motzer RJ, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J. Natl. Cancer Inst. 1994;86:1517–1524
  35. Chou TC. Drug combinations: from laboratory to practice. J. Lab. Clin. Med. 1998;132:6–8
  36. Baatout S, Derradji H, Jacquet P, Ooms D, Michaux A, Mergeay M. Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int. J. Mol. Med. 2004;13:895–902
  37. Baatout S, Derradji H, Jacquet P, Mergeay M. Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma. Int. J. Mol. Med. 2005;15:337–352
  38. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, et al. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 2002;175:165–173
  39. Berenbaum MC. What is synergy?. Pharmacol. Rev. 1989;41:93–141
  40. Perez CA, Michalski J, Ballard S, Drzymala R, Kobeissi BJ, Lockett MA, et al. Cost benefit of emerging technology in localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:875–883

PII: S0304-3835(07)00032-8

doi: 10.1016/j.canlet.2007.01.014

Cancer Letters
Volume 253, Issue 1 , Pages 124-130 , 8 August 2007

Article Tools

* Image Usage & Resolution